Features
Latest Practical Patient Care Feature
Surgical resection of cancerous tissue tends to include a “safety margin”...
> read more
The paradigm shift Checkpoint inhibitors have revolutionised cancer care. Stimulating the immune system is now as much of a focus in oncology as killing or surgically removing cancers. It’s a more...
The positive test The Covid-19 pandemic provided the impetus for unprecedented speed in the development of testing methods, as the industry collaborated, and regulators worldwide supported their...
The next phage While bacteria are responsible for a laundry list of diseases, they have their own enemy in the form of bacteriophages (viruses that infect bacteria). In turn, bacteriophages might...
Monkeying around It’s always been a cliché that bad things happen in pairs – and the arrival of monkeypox just as the Covid pandemic began to recede has done little to disprove the theory. But beyond...
The aftershock Septic shock is the most severe result of sepsis – an overreaction from the immune system to bacterial, fungal or viral infection. As with other acute conditions, time is of the...
Pressure point Pressure ulcers are among the most serious dangers to bedbound hospital and care home patients, which makes sense if you understand how they form. Developing from the pressure caused...
US FDA approves Pfizer-BioNTech, Moderna Covid-19 vaccines for kids aged six months The US agency expanded EUAs for the Pfizer-BioNTech and Moderna Covid-19 vaccines to include their use in children aged six months to four years, and six months to 17 years, respectively
Roche gets EC approval for Lunsumio to treat follicular lymphoma The EC approval is based on positive results from the Phase ½ GO29781 study, which assessed the safety, efficacy and pharmacokinetics of Lunsumio in people with B-cell non-Hodgkin lymphoma
Pfizer wraps up acquisition of RSV therapeutics company ReViral The acquisition will provide Pfizer with ReViral’s portfolio of therapeutic candidates, including sisunatovir, along with another lead candidate, focused on RSV replication
US FDA requires patient notification about suicide risk related to finasteride The US regulator required a patient notification about suicidal behaviour, where it has previously approved an expanded its label indication to include risks of persistent...
GSK’s RSV vaccine for older adults shows positive outcomes in Phase 3 trial The company’s investigational RSV vaccine candidate RSVPreF3 OA has showed statistically significant and clinically meaningful efficacy in adults aged 60 years and above
Amylyx secures Health Canada approval for Albrioza to treat ALS Albrioza, also known as AMX0035, is an oral fixed-dose combination therapy that works to reduce neuronal cell death and is the first new ALS therapy approved in Canada since 2018
Weaponising data to fight infection in hospitals Healthcare-associated infections are one of the greatest preventable threats to patient safety. In addition to causing suffering, they can do lasting, economic damage to...
Laser photobiomodulation for faster healing and pain management Light therapy has been increasingly used for a wide variety of medical applications. However, treatments for wound healing and pain management are the most commonly used applications...
Battling the resistance Abbott is an expert in the use of rapid diagnostics to help combat antimicrobial resistance globally, and has a refined understanding of the role education plays in enabling...
Putting antibiotic resistance to the test Just like other organisms, disease-causing bacteria evolve defence mechanisms that allow it to survive when patients are treated with antibiotics. A liberal approach to prescribing...
Embracing preanalytics for better diagnostics When swabbing became an all-too-familiar experience, testing and screening were understood as vital processes in the fight against viral infection. Sampling was identified as a...
Complete test portfolio for Lyme disease diagnostics A comprehensive portfolio of Borrelia antibody test systems from EUROIMMUN enables qualified two-step Lyme disease diagnostics according to the latest recommendations. Screening...
A rapid response to the pandemic As the world continues to deal with Covid-19, quick and accurate testing is still one of the best ways to slow its spread and protect the most vulnerable in our communities....
View all features A-Z
